MedTrace Logo

Frailty and Non-Fragile Congenital Heart Disease

NCT05824650 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2024-05-16

No results posted yet for this study

Summary

Congenital heart disease (CHD) is defined as congenital functional or anatomical abnormalities of the heart and intrathoracic great vessels. This study, which is planned to be carried out, will enable people with CHD to present a holistic perspective when planning rehabilitation programs and to create a common language for all health professionals.

Conditions

Interventions

OTHER

Observational

Individuals will be evaluated observationally in a 45-minute period in one day.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-20
Primary Completion
2024-01-15
Completion
2024-02-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05824650 on ClinicalTrials.gov